科美诊断
(688468)
| 流通市值：31.81亿 | | | 总市值：31.81亿 |
| 流通股本：4.01亿 | | | 总股本：4.01亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 164,615,385.76 | 81,300,127.46 | 436,289,767.28 | 343,786,670.77 |
| 营业收入 | 164,615,385.76 | 81,300,127.46 | 436,289,767.28 | 343,786,670.77 |
| 二、营业总成本 | 143,896,966.91 | 69,560,268.14 | 324,403,625.57 | 234,109,060.4 |
| 营业成本 | 53,161,388.58 | 26,929,340.63 | 110,426,416.99 | 81,313,289.8 |
| 税金及附加 | 2,687,654.82 | 1,340,819.3 | 6,643,735.97 | 4,436,674.32 |
| 销售费用 | 31,173,715.67 | 13,937,159.65 | 81,810,179.86 | 62,396,990.1 |
| 管理费用 | 22,346,481.33 | 10,566,042.73 | 52,714,670.14 | 40,384,056.02 |
| 研发费用 | 35,683,819.95 | 17,156,877.91 | 75,822,243.6 | 48,830,331.8 |
| 财务费用 | -1,156,093.44 | -369,972.08 | -3,013,620.99 | -3,252,281.64 |
| 其中:利息费用 | 3,377,397.07 | 1,724,478.85 | 5,237,706.28 | 3,060,372.06 |
| 其中:利息收入 | 4,594,395.73 | 2,115,749.46 | 8,267,694.61 | 6,437,083.86 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 5,518,494.99 | 3,527,427.45 | 11,519,262.77 | 9,962,390.73 |
| 资产处置收益 | 97,479.89 | 21,394.66 | 510,562.26 | 483,386.53 |
| 资产减值损失(新) | -3,287,141.59 | -1,389,870.16 | -6,359,721.76 | -3,496,784.13 |
| 信用减值损失(新) | 81,589.49 | 64,601.15 | 200,684.49 | -46,430.86 |
| 其他收益 | 4,580,079.61 | 632,469.98 | 16,985,235.82 | 11,560,836.42 |
| 四、营业利润 | 27,708,921.24 | 14,595,882.4 | 134,742,165.29 | 128,141,009.06 |
| 加:营业外收入 | 298,166.06 | 160,576.26 | 3,818,861.45 | 236,010.55 |
| 减:营业外支出 | 176,302.37 | 158,672.03 | 642,200.77 | 458,968.55 |
| 五、利润总额 | 27,830,784.93 | 14,597,786.63 | 137,918,825.97 | 127,918,051.06 |
| 减:所得税费用 | 3,489,954.17 | 54,972.79 | 10,844,108.58 | 15,767,090.59 |
| 六、净利润 | 24,340,830.76 | 14,542,813.84 | 127,074,717.39 | 112,150,960.47 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 24,340,830.76 | 14,542,813.84 | 127,074,717.39 | 112,150,960.47 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 24,340,830.76 | 14,542,813.84 | 127,074,717.39 | 112,150,960.47 |
| 扣除非经常损益后的净利润 | 15,919,014.58 | 11,131,421.96 | 100,730,232.14 | 94,400,679.82 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.06 | 0.04 | 0.32 | 0.28 |
| (二)稀释每股收益 | 0.06 | 0.04 | 0.32 | 0.28 |
| 九、综合收益总额 | 24,340,830.76 | 14,542,813.84 | 127,074,717.39 | 112,150,960.47 |
| 归属于母公司股东的综合收益总额 | 24,340,830.76 | 14,542,813.84 | 127,074,717.39 | 112,150,960.47 |
| 公告日期 | 2025-08-30 | 2025-04-29 | 2025-04-29 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |